本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Theriva Biologics

1.36
+0.03502.65%
盘后1.360.00000.00%17:47 EDT
成交量:1.24万
成交额:1.62万
市值:377.08万
市盈率:-0.07
高:1.36
开:1.26
低:1.25
收:1.32
数据加载中...
2025/03/31

重要事件披露

Form 8-K - Current report
2025/03/21

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/03/07

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/07

重要事件披露

Form 8-K - Current report
2025/01/21

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/12/10

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/12/05

重要事件披露

Form 8-K - Current report
2024/11/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/01

重要事件披露

Form 8-K - Current report
2024/10/16

重要事件披露

Form 8-K - Current report
2024/10/03

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/03

重要事件披露

Form 8-K - Current report
2024/10/02

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/30

重要事件披露

Form 8-K - Current report
2024/09/23

SEC问询函

Form CORRESP - Correspondence
2024/09/23

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/09/23

重要事件披露

Form 8-K - Current report
2024/09/20

SEC问询函

Form CORRESP - Correspondence